|

Midazolam Hydrochloride Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • University Hospital of North Norway1
  • University Health Network, Toronto1

Indications

  • Depression2
  • Treatment-resistant Depression1
  • Suicide1
  • Major Depressive Disorder1
  • Alcohol Use Disorder1

Other2 trials

Ketamine for Combined Depression and Alcohol Use Disorder
Phase 1/2
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.